The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-(tert-Butyl)-1-(3-cyanophenyl)-1H-pyrazol-5-yl)-3-(4-((8-(cyclopropylamino)imidazo[1,2-a]pyrazin-5-yl)oxy)-3-methylphenyl)urea ID: ALA4526846
PubChem CID: 155544178
Max Phase: Preclinical
Molecular Formula: C31H31N9O2
Molecular Weight: 561.65
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(C#N)c2)ccc1Oc1cnc(NC2CC2)c2nccn12
Standard InChI: InChI=1S/C31H31N9O2/c1-19-14-22(10-11-24(19)42-27-18-34-28(35-21-8-9-21)29-33-12-13-39(27)29)36-30(41)37-26-16-25(31(2,3)4)38-40(26)23-7-5-6-20(15-23)17-32/h5-7,10-16,18,21H,8-9H2,1-4H3,(H,34,35)(H2,36,37,41)
Standard InChI Key: WUMNDTDFFMQBMZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
42 47 0 0 0 0 0 0 0 0999 V2000
4.6482 -17.5335 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0568 -16.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6482 -16.1194 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8739 -16.8244 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2825 -17.5335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0997 -17.5335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5083 -18.2426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0997 -18.9475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2825 -18.9475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8739 -18.2426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3255 -18.2426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5083 -19.6566 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5513 -20.3657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9599 -19.6566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7341 -20.3657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5513 -18.9475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7341 -18.9475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3255 -19.6566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8060 -21.1429 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1427 -21.6231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4836 -21.1429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7771 -19.6566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1857 -18.9475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1857 -18.1303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8948 -18.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3508 -18.1967 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5736 -17.9421 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5736 -17.1249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3508 -16.8743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8310 -17.5335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6055 -18.9698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4039 -19.1406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6586 -19.9178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1107 -20.5284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3123 -20.3577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0576 -19.5804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4569 -20.0886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2553 -20.2593 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9145 -16.6447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1672 -16.9791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9985 -15.8302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2010 -16.2324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
5 10 2 0
7 11 1 0
13 14 1 0
13 15 1 0
14 16 2 0
16 17 1 0
17 18 2 0
15 18 1 0
19 20 1 0
20 21 2 0
15 21 1 0
13 19 2 0
23 24 1 0
24 25 1 0
23 25 1 0
22 23 1 0
14 22 1 0
12 18 1 0
8 12 1 0
4 5 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
26 30 1 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
31 36 2 0
37 38 3 0
33 37 1 0
26 31 1 0
39 40 1 0
39 41 1 0
28 39 1 0
1 30 1 0
39 42 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 561.65Molecular Weight (Monoisotopic): 561.2601AlogP: 6.40#Rotatable Bonds: 7Polar Surface Area: 134.19Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 3CX Acidic pKa: 11.47CX Basic pKa: 3.33CX LogP: 5.29CX LogD: 5.29Aromatic Rings: 5Heavy Atoms: 42QED Weighted: 0.21Np Likeness Score: -2.01
References 1. Kang SJ, Lee JW, Chung SH, Jang SY, Choi J, Suh KH, Kim YH, Ham YJ, Min KH.. (2019) Synthesis and anti-tumor activity of imidazopyrazines as TAK1 inhibitors., 163 [PMID:30576901 ] [10.1016/j.ejmech.2018.12.025 ]